EBITDA Growth
-952.07%
Quarterly · Period ending:
GYRE EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-952.07%period ending
Latest reported-952.07%period ending
GYRE Quarterly EBITDA YoY % (-108043.04% → -952.07%)
Year-over-year change
High-resolution chart · PNG
GYRE ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -952.0715% | |
| -265.6673% | |
| -44.5326% | |
| 89.2114% | |
| -119.6238% | |
| -59.91% | |
| 123.2329% | |
| -61.5891% | |
| 1.6364% | |
| 96.6753% | |
| -255.3785% | |
| 1,081.1962% | |
| 209.2776% | |
| 144.9479% | |
| 93.2% | |
| 95.3849% | |
| 71.5938% | |
| 34.8546% | |
| -7.083% | |
| -56.6384% | |
| -15.4512% | |
| -455.9335% | |
| -38.9364% | |
| -26.7103% | |
| -25.2874% | |
| 73.2145% | |
| -16.5822% | |
| -52.5214% | |
| -94.2348% | |
| -126.2714% | |
| -101.1921% | |
| -42.3505% | |
| -19.9288% | |
| -61.1933% | |
| -56.8989% | |
| -25.1769% | |
| -25.0742% | |
| 7.7009% | |
| 19.4366% | |
| -39.111% | |
| -120.056% | |
| -49.6984% | |
| -0.7702% | |
| -124.9664% | |
| -0.1401% | |
| 74.0725% | |
| 65.8551% | |
| 88.2603% | |
| 83.457% | |
| -47.1739% | |
| 21.5284% | |
| -73.6489% | |
| -168.6287% | |
| -493.7563% | |
| -85.4253% | |
| 21.6697% | |
| 833.4889% | |
| -83.8563% | |
| -1,905.7018% | |
| -382.0738% | |
| -155.4334% | |
| 61.4012% | |
| 98.2408% | |
| 329.6104% | |
| 150.7495% | |
| 281.4762% | |
| -1.9529% | |
| 100.0094% | |
| 99.8771% | |
| 99.9373% | |
| 99.9099% | |
| -10.0258% | |
| 18.0513% | |
| -123,329.9582% | |
| 3.4426% | |
| -31.2631% | |
| -70.6639% | |
| 99.9327% | |
| -444,246.4084% | |
| -80,979.6422% | |
| -65,242.8505% | |
| -108,043.0446% |